World News: 13:00 GMT Monday 31st July 2017. [RedHill Biopharma Ltd. via Thomson Reuters ONE via SPi World News]
The independent Data and Safety Monitoring Board DSMB reviewed safety and efficacy data of which RedHill remains blinded from the first 222 subjects who have completed week 26 assessments in the Phase III MAP US study To date over 300 of the...
Thomson Reuters: 13:00 GMT Monday 31st July 2017
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.